Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Seyhan Boyoglu-Barnum

Dr. Seyhan Boyoglu-Barnum

Scientific Review Officer



Biography

Division:
Division of Physiological and Pathological Sciences – DPPS
Review Branch:
Immunology and Infectious Diseases A – IIDA

Dr. Seyhan Boyoglu-Barnum earned her Ph.D. from Alabama State University and completed postdoctoral training at Emory University, specializing in RSV vaccine development. Dr. Boyoglu-Barnum contributed to the MERS outbreak response at the CDC’s Division of Viral Diseases and joined the NIH Vaccine Research Center (VRC) in 2016, where she led mosaic influenza vaccine studies and preclinical studies for the COVID-19 pandemic response. She has served as an editor for multiple immunology and virology journals, authored approximately 60 peer-reviewed publications, and holds several patents. Prior to joining CSR, Dr. Boyoglu-Barnum was Senior Manager/Acting Director at GlaxoSmithKline (GSK), where she led U.S. scientific communications and supported viral vaccine R&D.

 

Last updated: 09/18/2025 05:01